- Home
- CCCC vs UHG Comparison
CCCC vs UHG Comparison
Compare CCCC & UHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- UHG
- Stock Information
- Founded
- CCCC 2015
- UHG 2004
- Country
- CCCC United States
- UHG United States
- Employees
- CCCC N/A
- UHG N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- UHG Homebuilding
- Sector
- CCCC Health Care
- UHG Consumer Discretionary
- Exchange
- CCCC Nasdaq
- UHG Nasdaq
- Market Cap
- CCCC 104.4M
- UHG 158.8M
- IPO Year
- CCCC 2020
- UHG N/A
- Fundamental
- Price
- CCCC $2.35
- UHG $2.95
- Analyst Decision
- CCCC Buy
- UHG
- Analyst Count
- CCCC 3
- UHG 0
- Target Price
- CCCC $12.00
- UHG N/A
- AVG Volume (30 Days)
- CCCC 1.6M
- UHG 231.7K
- Earning Date
- CCCC 07-31-2025
- UHG 08-07-2025
- Dividend Yield
- CCCC N/A
- UHG N/A
- EPS Growth
- CCCC N/A
- UHG N/A
- EPS
- CCCC N/A
- UHG 0.76
- Revenue
- CCCC $39,783,000.00
- UHG $449,877,017.00
- Revenue This Year
- CCCC N/A
- UHG N/A
- Revenue Next Year
- CCCC N/A
- UHG N/A
- P/E Ratio
- CCCC N/A
- UHG $4.06
- Revenue Growth
- CCCC 98.56
- UHG 5.24
- 52 Week Low
- CCCC $1.09
- UHG $1.60
- 52 Week High
- CCCC $7.66
- UHG $6.93
- Technical
- Relative Strength Index (RSI)
- CCCC 63.62
- UHG 49.50
- Support Level
- CCCC $1.36
- UHG $2.71
- Resistance Level
- CCCC $2.17
- UHG $2.95
- Average True Range (ATR)
- CCCC 0.15
- UHG 0.33
- MACD
- CCCC 0.05
- UHG -0.07
- Stochastic Oscillator
- CCCC 67.11
- UHG 28.24
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About UHG United Homes Group Inc
United Homes Group Inc operates as a homebuilder which operates with a land-light idea in the Southeast. The company currently has a presence in South Carolina, North Carolina, and Georgia and focuses on providing high-quality, affordable homes for the entry-level and first-move-up segments. The company has three reportable segments: GSH South Carolina, Rosewood, and Other.